Nasal spray maker clinches first PhIII win it needs to reach a much, much bigger market - Endpoints News
3/7/2022 12:00:00 AM3 years 1 month ago
by Amber Tong
by Amber Tong
Four and a half years after first going public on the promise of building out a franchise for its nasal spray, Optinose says it has the landmark Phase III data to finally move forward. The Yardley, PA-based biotech is reporting positive topline results from R…
Four and a half years after first going public on the promise of building out a franchise for its nasal spray, Optinose says it has the landmark Phase III data to finally move forward. The Yardley, … [+2042 chars]
full article...